The Trump administration has moved to secure almost all stocks of the drug remdesivir until October, leaving public health experts fearing many other countries, including Australia, will miss out on accessing the treatment
There are fears Australia is amongst many other countries barred from accessing new Coronavirus treatments after the United States moved to secure near-exclusive access to the antiviral drug remdesivir for the next three months.
Read the full article in English here.
Share
